Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tumour cell death induced by NAC

Abstract Background The tumour microenvironment consists of malignant cells, stroma and immune cells. In women with large and locally advanced breast cancers (LLABCs) undergoing neoadjuvant chemotherapy (NAC), tumour-infiltrating lymphocytes (TILs), various subsets (effector, regulatory) and cytokin...

Full description

Bibliographic Details
Main Authors: Viriya Kaewkangsadan, Chandan Verma, Jennifer M. Eremin, Gerard Cowley, Mohammad Ilyas, Oleg Eremin
Format: Article
Language:English
Published: BMC 2018-02-01
Series:BMC Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12885-018-4044-z
id doaj-b3a29112dfc646b3804dfd0a20728dd6
record_format Article
spelling doaj-b3a29112dfc646b3804dfd0a20728dd62020-11-25T01:49:07ZengBMCBMC Cancer1471-24072018-02-0118111410.1186/s12885-018-4044-zTumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tumour cell death induced by NACViriya Kaewkangsadan0Chandan Verma1Jennifer M. Eremin2Gerard Cowley3Mohammad Ilyas4Oleg Eremin5Division of Gastrointestinal Surgery, Nottingham Digestive Diseases Centre, Faculty of Medicine and Health Sciences, University of NottinghamDivision of Gastrointestinal Surgery, Nottingham Digestive Diseases Centre, Faculty of Medicine and Health Sciences, University of NottinghamResearch & Development Department, Lincoln Breast Unit, Lincoln County HospitalDepartment of Pathology, PathLinks, Lincoln County Hospital, Greetwell RoadAcademic Department of Pathology, Faculty of Medicine and Health Sciences, University of NottinghamDivision of Gastrointestinal Surgery, Nottingham Digestive Diseases Centre, Faculty of Medicine and Health Sciences, University of NottinghamAbstract Background The tumour microenvironment consists of malignant cells, stroma and immune cells. In women with large and locally advanced breast cancers (LLABCs) undergoing neoadjuvant chemotherapy (NAC), tumour-infiltrating lymphocytes (TILs), various subsets (effector, regulatory) and cytokines in the primary tumour play a key role in the induction of tumour cell death and a pathological complete response (pCR) with NAC. Their contribution to a pCR in nodal metastases, however, is poorly studied and was investigated. Methods Axillary lymph nodes (ALNs) (24 with and 9 without metastases) from women with LLABCs undergoing NAC were immunohistochemically assessed for TILs, T effector and regulatory cell subsets, NK cells and cytokine expression using labelled antibodies, employing established semi-quantitative methods. IBM SPSS statistical package (21v) was used. Non-parametric (paired and unpaired) statistical analyses were performed. Univariate and multivariate regression analyses were carried out to establish the prediction of a pCR and Spearman’s Correlation Coefficient was used to determine the correlation of immune cell infiltrates in ALN metastatic and primary breast tumours. Results In ALN metastases high levels of TILs, CD4+ and CD8+ T and CD56+ NK cells were significantly associated with pCRs.. Significantly higher levels of Tregs (FOXP3+, CTLA-4+) and CD56+ NK cells were documented in ALN metastases than in the corresponding primary breast tumours. CD8+ T and CD56+ NK cells showed a positive correlation between metastatic and primary tumours. A high % CD8+ and low % FOXP3+ T cells and high CD8+: FOXP3+ ratio in metastatic ALNs (tumour-free para-cortex) were associated with pCRs. Metastatic ALNs expressed high IL-10, low IL-2 and IFN-ϒ. Conclusions Our study has provided new data characterising the possible contribution of T effector and regulatory cells and NK cells and T helper1 and 2 cytokines to tumour cell death associated with NAC in ALNs. Trial registration The Trial was retrospectively registered. Study Registration Number is ISRCTN00407556.http://link.springer.com/article/10.1186/s12885-018-4044-zAxillary lymph nodeBreast cancerNeoadjuvant chemotherapyTumour microenvironmentTumour-infiltrating lymphocyte subsetsCytokines
collection DOAJ
language English
format Article
sources DOAJ
author Viriya Kaewkangsadan
Chandan Verma
Jennifer M. Eremin
Gerard Cowley
Mohammad Ilyas
Oleg Eremin
spellingShingle Viriya Kaewkangsadan
Chandan Verma
Jennifer M. Eremin
Gerard Cowley
Mohammad Ilyas
Oleg Eremin
Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tumour cell death induced by NAC
BMC Cancer
Axillary lymph node
Breast cancer
Neoadjuvant chemotherapy
Tumour microenvironment
Tumour-infiltrating lymphocyte subsets
Cytokines
author_facet Viriya Kaewkangsadan
Chandan Verma
Jennifer M. Eremin
Gerard Cowley
Mohammad Ilyas
Oleg Eremin
author_sort Viriya Kaewkangsadan
title Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tumour cell death induced by NAC
title_short Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tumour cell death induced by NAC
title_full Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tumour cell death induced by NAC
title_fullStr Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tumour cell death induced by NAC
title_full_unstemmed Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tumour cell death induced by NAC
title_sort tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (nac): the crucial contribution of immune cells (effector, regulatory) and cytokines (th1, th2) to immune-mediated tumour cell death induced by nac
publisher BMC
series BMC Cancer
issn 1471-2407
publishDate 2018-02-01
description Abstract Background The tumour microenvironment consists of malignant cells, stroma and immune cells. In women with large and locally advanced breast cancers (LLABCs) undergoing neoadjuvant chemotherapy (NAC), tumour-infiltrating lymphocytes (TILs), various subsets (effector, regulatory) and cytokines in the primary tumour play a key role in the induction of tumour cell death and a pathological complete response (pCR) with NAC. Their contribution to a pCR in nodal metastases, however, is poorly studied and was investigated. Methods Axillary lymph nodes (ALNs) (24 with and 9 without metastases) from women with LLABCs undergoing NAC were immunohistochemically assessed for TILs, T effector and regulatory cell subsets, NK cells and cytokine expression using labelled antibodies, employing established semi-quantitative methods. IBM SPSS statistical package (21v) was used. Non-parametric (paired and unpaired) statistical analyses were performed. Univariate and multivariate regression analyses were carried out to establish the prediction of a pCR and Spearman’s Correlation Coefficient was used to determine the correlation of immune cell infiltrates in ALN metastatic and primary breast tumours. Results In ALN metastases high levels of TILs, CD4+ and CD8+ T and CD56+ NK cells were significantly associated with pCRs.. Significantly higher levels of Tregs (FOXP3+, CTLA-4+) and CD56+ NK cells were documented in ALN metastases than in the corresponding primary breast tumours. CD8+ T and CD56+ NK cells showed a positive correlation between metastatic and primary tumours. A high % CD8+ and low % FOXP3+ T cells and high CD8+: FOXP3+ ratio in metastatic ALNs (tumour-free para-cortex) were associated with pCRs. Metastatic ALNs expressed high IL-10, low IL-2 and IFN-ϒ. Conclusions Our study has provided new data characterising the possible contribution of T effector and regulatory cells and NK cells and T helper1 and 2 cytokines to tumour cell death associated with NAC in ALNs. Trial registration The Trial was retrospectively registered. Study Registration Number is ISRCTN00407556.
topic Axillary lymph node
Breast cancer
Neoadjuvant chemotherapy
Tumour microenvironment
Tumour-infiltrating lymphocyte subsets
Cytokines
url http://link.springer.com/article/10.1186/s12885-018-4044-z
work_keys_str_mv AT viriyakaewkangsadan tumourdrainingaxillarylymphnodesinpatientswithlargeandlocallyadvancedbreastcancersundergoingneoadjuvantchemotherapynacthecrucialcontributionofimmunecellseffectorregulatoryandcytokinesth1th2toimmunemediatedtumourcelldeathinducedbynac
AT chandanverma tumourdrainingaxillarylymphnodesinpatientswithlargeandlocallyadvancedbreastcancersundergoingneoadjuvantchemotherapynacthecrucialcontributionofimmunecellseffectorregulatoryandcytokinesth1th2toimmunemediatedtumourcelldeathinducedbynac
AT jennifermeremin tumourdrainingaxillarylymphnodesinpatientswithlargeandlocallyadvancedbreastcancersundergoingneoadjuvantchemotherapynacthecrucialcontributionofimmunecellseffectorregulatoryandcytokinesth1th2toimmunemediatedtumourcelldeathinducedbynac
AT gerardcowley tumourdrainingaxillarylymphnodesinpatientswithlargeandlocallyadvancedbreastcancersundergoingneoadjuvantchemotherapynacthecrucialcontributionofimmunecellseffectorregulatoryandcytokinesth1th2toimmunemediatedtumourcelldeathinducedbynac
AT mohammadilyas tumourdrainingaxillarylymphnodesinpatientswithlargeandlocallyadvancedbreastcancersundergoingneoadjuvantchemotherapynacthecrucialcontributionofimmunecellseffectorregulatoryandcytokinesth1th2toimmunemediatedtumourcelldeathinducedbynac
AT olegeremin tumourdrainingaxillarylymphnodesinpatientswithlargeandlocallyadvancedbreastcancersundergoingneoadjuvantchemotherapynacthecrucialcontributionofimmunecellseffectorregulatoryandcytokinesth1th2toimmunemediatedtumourcelldeathinducedbynac
_version_ 1725008815305261056